About Kores
Kores is a company based in Mumbai (India) founded in 1932. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. The company has 817 employees as of March 29, 2024. Kores offers products and services including Stationery Products, Engineering Solutions, Foundry Castings, Business Automation, and Pharmaceutical Drugs. Kores operates in a competitive market with competitors including Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
- Headquarter Mumbai, India
- Employees 817 as on 29 Mar, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kores India Ltd.
- Date of Incorporation 26 May, 1936
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$114.51 M (USD)24.5as on Mar 31, 2023
-
Net Profit
$3.22 M (USD)66.12as on Mar 31, 2023
-
EBITDA
$8 M (USD)18.74as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
817
as on Mar 29, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kores
Kores offers a comprehensive portfolio of products and services, including Stationery Products, Engineering Solutions, Foundry Castings, Business Automation, and Pharmaceutical Drugs.
Stationery products are offered for domestic and global markets.
Core drilling solutions are provided for various project needs.
High-quality metal castings are crafted for multiple industries.
Automation solutions are delivered to enhance company potential.
Life-changing drugs are developed for patient health improvement.
Funding Insights of Kores
Detailed funding history for Kores
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kores
Investment portfolio details for Kores
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kores
Detailed financials for Kores
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kores Comparisons
Peer comparison for Kores
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kores
Kores operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Sterling Pharma Solutions, Provepharm Life Solutions and Jubilant Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
Detailed competitors of Kores
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kores
Complete news archive for Kores
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kores
Kores was founded in 1932.
Kores is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Sunil Pudi is the current CEO of Kores.
As of Mar 29, 2024, the latest employee count at Kores is 817.
Annual revenue of Kores is $114.51M as on Mar 31, 2023.
Kores is established as a diversified conglomerate with a global presence, operating across multiple industries including stationery, engineering, foundry, business automation, and pharmaceuticals. Products and services are provided to both domestic and international markets. Solutions such as core drilling equipment, high-quality metal castings, and life-changing drugs are developed. Business automation tools are offered to unlock company potential. The commitment to innovation, collaboration, and excellence is maintained to ensure a positive impact on lives.
Kores's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Kores offers Stationery Products, Engineering Solutions, Foundry Castings, Business Automation, and Pharmaceutical Drugs.